Lates News

After Thermo Fisher Scientific released its performance and outlook, the stock prices of biotechnology and medical device companies fell. Revvity's stock price fell by 15.5%, Bio-Techne's stock price fell by 10.1%, Illumina's stock price fell by 8.3%, and Charles River Laboratories' stock price fell by 7%.